ACCESS CLINICAL TRIAL PUBLICATIONS FOR TOUJEO®

Toujeo® has been studied versus Lantus® (insulin glargine injection) 100 Units/mL in four pivotal clinical trials (the EDITION study program)a involving more than 3000 patients and in two euglycemic clamp studies to assess pharmacokinetics (PK) and pharmacodynamics (PD).1-7

Use the links below to read the study abstracts at PubMed.gov.